Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion type Assertion NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_head.
- NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion description "[The focus of this manuscript is to provide an update of the programmes in the US and Canada, provide data in support of p24 antigen replacement by HIV-1 NAT, and discuss the projections of residual risk of HIV, HCV and HBV following NAT and the associated cost/benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_provenance.
- NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion evidence source_evidence_literature NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_provenance.
- NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion SIO_000772 12220142 NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_provenance.
- NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion wasDerivedFrom befree-20150227 NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_provenance.
- NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_assertion wasGeneratedBy ECO_0000203 NP973244.RABxJbC9-3I7hd1fo5mYYHmuZ96n4Wsd82VP3du5mQigI130_provenance.